Value of C-reactive protein measurement in hospitalized patients with acute exacerbations of chronic obstructive pulmonary disease

Medical Journal of Wuhan University

Volumn 27, Issue 5, 2006, Pages 660-663

  Ding, Xuhong ^a   Wu, Xiaojun ^a   Yu, Changping ^a   Hu, Suping ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Acute Exacerbation; C reactive Protein; COPD; FEV1

Indexed keywords

C REACTIVE PROTEIN;

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; FORCED EXPIRATORY VOLUME; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; PROTEIN BLOOD LEVEL; SPIROMETRY;

EID: 33845500084     PISSN: 16718852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Almirall J, Boliber I, Toran P, et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia[J]. Chest, 2004, 125(4):1 335-1 342.
2. Vazquez EG, Martinez JA, Mensa J, et al. C-reactive protein levels in community-acquired pneumonia[J]. Eur Respir J, 2003, 21(3):702-705.
3. Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease [J]. Circulation, 2003, 107(11):1 514-1 519.
4. Gan WQ, Man SFP, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis[J]. Thorax, 2004, 59(7):574-580.
5. Stockley RA, O'Brien C, Pye A, et al. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD[J]. Chest, 2000, 117(6): 1 638-1 645.
6. Dev D, Wallace E, Sankaran R, et al. Value of C-reactive protein measurements in exacerbations of chronic obstructive pulmonary disease[J]. Respir Med, 1998, 92(4):664-667.
7. Anthonisen NR, Manfreda J, Warren CPW, et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease[J]. Ann Intern Med, 1987, 106 (2): 196-204.
8. Weis N, Almdal T. C-reactive protein-can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease[J]. Eur J Intern Med, 2006, 17(2): 88-91.
9. Gompertz S, O'Brien C, Bayley DL, et al. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis[J]. Eur Respir J, 2001, 17(6): 1 112-1 119.
10. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers[J]. Am J Respir Crit Care Med, 1998, 158(4): 1 277-1 285.
11. Hurst JR, Perera WR, Wilkinson TM, et al. Systemic and upper and lower airway inflammation at exacerbations of chronic obstructive pulmonary disease[J]. Am J Respir Crit Care Med, 2006, 173(1):71-78